Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, and HIV-related health complications and treatments.
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV.
Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study.
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.
High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.
Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.
Comparison of central obesity prevalence among adults living with and without HIV in Botswana: a cross-sectional study
Brief Report: Predictors of Concurrent Sexual Partnerships and Association With Recent HIV Infection in a Large Population-Based Survey in Botswana.
High prevalence of albuminuria among adult males living with HIV in Botswana
Self-reported cardiovascular disease risk factor screening among people living with HIV vs. members of the general population in Botswana: a community-based study
Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana.
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana.
Emergence of Omicron FN.1 a descendent of BQ.1.1 in Botswana.
Rapid dynamic changes of FL.2 variant: A case report of COVID-19 breakthrough infection.
Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
Emulating Target Trials to Avoid Immortal Time Bias – An Application to Antibiotic Initiation and Preterm Delivery
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana
No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants.
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana
Approaches to accelerating the study of new antiretrovirals in pregnancy.
HIV and Hodgkin Lymphoma Survival: A Prospective Study in Botswana.
Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
Time for a Change: Optimizing Drug Data and Informed Choice in Pregnancy.
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana
An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh
ASSESSMENT OF PERFORMANCE AND IMPLEMENTATION CHARACTERISTICS OF RAPID POINT OF CARE SARS-CoV-2 ANTIGEN TESTING